Australia HQ

28 Dalgleish Street, Thebarton South Australia 5031

News: Company News

​Agilex Biolabs   →  News   →  Company News
31
Aug
Date August 31, 2021
Categories Company News, Webinars

Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia

Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.
Read More
Author Editor
14
Jul
Date July 14, 2021
Categories Company News

Premier Launches $1.5m Vaccine and Immunobiology State-of-the-art Laboratory

Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical laboratory for clinical trials today announced that the Premier of South Australia the Hon Steven Marshall MP has launched its new $1.5m vaccine and immuno-biology laboratory. The facility, the most sophisticated in APAC, will attract biotechs and pharma from around the world for advanced clinical research.

Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Read More
Author Editor
12
Jun
Date June 12, 2021
Categories Company News, Conferences

Agilex Biolabs Completes Refurbishment of Labs Expansion at Australian HQ and Adds New Toxicology Facility to Offering

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials announced for BIO Korea 2021 that their upgraded and expanded biolabs at the Australian headquarters is now complete.

The labs have been expanded by 30% to cater for increased demand for bioanalysis and biomarkers in clinical studies from clinical stage biotechs.
Read More
Author Editor
17
May
Date May 17, 2021
Categories Company News

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia.

TetraQ is a NATA-accredited, GLP-recognised rodent toxicology facility.
Read More
Author Editor
07
Apr
Date April 7, 2021
Categories Company News

Agilex Biolabs Buys Leading Biolab TetraQ as Part of APAC Expansion Plans

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the purchase of leading biolab TetraQ, based out of the University of Queensland.

Agilex Biolabs CEO Jason Valentine said the Board and senior management at Agilex Biolabs were extremely pleased with the purchase of such a high-calibre bioanalytics company.

“TetraQ complements the Agilex Biolabs work in Australia and APAC with its expert staff and years of experience in regulated bioanalytical services,” he said.
Read More
Author Editor
1 2 3